By Michael Susin Arix Bioscience said Chief Executive Officer Robert Lyne will step down from the company by the end of 2023 to pursue a new opportunity. The.
PureTech Health plc , a clinical-stage biotherapeutics company dedicated to changing the lives of patients with devastating diseases, today announced the appointment of Robert Lyne as Chief.
The FTSE 100 closed Wednesday down 0.46%, having fluctuated between positive and negative territory. The worst performers could be found in commercial real estate, while Ocado traded sharply lower.
The chief executive of Arix Bioscience is to step down ahead of a possible winding-down of the former Neil Woodford-backed life sciences investment company.Robe